The company JOINT STOCK COMPANY "CHEMICO-PHARMACEUTICAL PLANT "AKRIKHIN" 5031013320 is registered at 142450, MOSCOW REGION, STARAYA KUPAVNA CITY, NOGINSKY DISTRICT, KIROVA STREET, 29. The organization was registered on 09.08.200 2. The organization was issued an All-Russian State Registration Number - 1025003911570. The organization is managed by the PRESIDENT CHETVERIKOV DENIS VALERIEVICH. In accordance with the registration documents, the main activity is the production of medicines and materials used for medical purposes. For more detailed information, you can go to the company’s card and check the reliability of the counterparty.
Interdistrict Inspectorate of the Federal Tax Service No. 23 for the Moscow Region registered AKRIKHIN JSC on 08/09/2002. Registration procedure for a State institution - Management Pension Fund RF No. 13 Noginsk district of the Moscow region was initiated on August 14, 2006. Registered with Branch No. 31 Government institution- Moscow regional branch of the Foundation social insurance Russian Federation the company JSC "AKRIKHIN" became 10/18/2008 00:00:00. The latest entry in the Unified State Register of Legal Entities, which contains about this company: State registration changes made to constituent documents legal entity related to changes in information about the legal entity contained in the Unified State Register legal entities, based on the application.
> Akrikhin, JSC (Moscow)
This information cannot be used for self-medication!
Consultation with a specialist is required!
The full name of the company is Akrikhin Chemical and Pharmaceutical Plant. Is Russian company, is engaged in the production of a variety of dosage forms: tablets, syrups, ointments, creams and capsules. Most of manufactured products are focused on socially significant therapeutic areas of medicine. These include endocrinology, cardiology, neurology, phthisiology, and gynecology.
In Russia, Akrikhin OJSC was officially registered in 2003, although the history of production begins in 1936, when the manufacturer produced a batch of the antimalarial drug Akrikhin, which later gave the company its name.
Currently, the actual owner of Akrikhin OJSC is the Hungarian pharmaceutical giant Gedeon Richter, which owns more than 80% of the company's shares. Another co-owner is the Polish pharmaceutical company Polpharma. Foreign investments allowed the chemical and pharmaceutical plant to enter the top ten Russian manufacturers medicines. About 40% of all manufactured drugs are included in the list of vital means
Akrikhin company produces the following drugs:
- gel Azelik to combat acne;
- creams and ointments for the treatment of atopic dermatitis and complicated dermatoses – Akriderm-Ghenta, Akriderm-GK;
- pills Acridilol And Acripamide for the treatment of coronary heart disease;
- Effervescent tablets for treating hangovers – Alca Prim;
- drops for children Bobotik from bloating;
- ointment and tablets Acyclovir-Acri for the treatment of herpes infection;
- painkiller Bystrumgel;
- means for the treatment of varicose veins - Venolife;
- drugs for the treatment of diabetes mellitus – Glidiab And Glymecombe;
- biologically active additive Zhuravit;
- anti-tuberculosis drugs - Isocomb, Pask-Acri, Pyrazinamide-Acri, Rifapex;
- remedy for the treatment of allergic reactions - Clarotadine tablets and syrup;
- antimicrobial agent Clindacin for the treatment of bacterial vaginosis;
- antidiarrheal drug Loperamide-Acree;
- medicinal shampoo Mycozoral with antifungal effect;
- eubiotics Normobakt, Normobakt Junior for the treatment of dysbacteriosis;
- Nozzle– patch for inhalation;
- ophthalmic biological additive – SuperOptic;
- Thrombopol– a blood thinner;
- drugs for the treatment of diseases of the musculoskeletal system – Febrofid-gel, Diclofenac;
- antihypertensive pills Enalapril-Acri;
- L-Thyroxine-Acri– a drug for the treatment of thyroid diseases.
"AKRIKHIN" Today it is one of the leading Russian pharmaceutical companies producing affordable, effective and high-quality medicines.
AKRIKHIN was founded in 1936. The company is among the top 10 largest local pharmaceutical manufacturers in terms of sales and production volume on the Russian pharmaceutical market.
The company's product portfolio includes more than 200 types of drugs (more than 100 brands) in the main pharmacotherapeutic areas: cardiology, neurology, dermatology, gynecology, pediatrics, ophthalmology, urology. These are drugs like own production"AKRIKHINA", and displayed on Russian market in partnership with other companies.
"AKRIKHIN" produces a wide range of socially significant, contributing to the development of the Russian healthcare system. The company is one of the largest Russian manufacturers of drugs included in the List of Vital and Essential Medicines (VED), as well as drugs for the treatment of tuberculosis and diabetes.
Production complex "AKRIKHINA" is located 20 km from Moscow. The company's production includes production workshops medicines almost all forms: tablets, capsules, liniments, ointments, creams, syrups, gels, suppositories, etc. The company's annual production volume is more than 50 million packages. are produced on foreign equipment from high-quality raw materials based on latest technologies. The modern warehouse complex "AKRIKHINA" has more than 8 thousand pallet spaces that ensure proper storage of medicines.
Since 2007, AKRIKHIN's strategic partner on the Russian pharmaceutical market has been Polpharma. Strategic cooperation between AKRIKHIN and Polpharma includes:
- unified product portfolio,
- transfer of production technologies and cooperation in the field of research and development,
- access to international management standards and technologies, employee training, exchange programs.
In 2011, Polpharma strengthened and expanded the partnership by acquiring a majority stake in AKRIKHIN.
Part production complex"AKRIKHINA" includes:
- 2 production facilities for the production of finished dosage forms:
- solid finished dosage forms,
- soft and liquid finished dosage forms;
- Quality Control Center;
- R&D laboratory;
- Finished goods warehouse;
- Bonded warehouse;
- Warehouse of raw materials and supplies.
Each stage of drug creation is accompanied by quality control. This is ensured by the company's quality assurance system. AKRIKHIN regularly successfully passes audits of foreign partners and regulatory authorities for compliance of the quality assurance system and quality management system with ISO standards and rules.
In 2010, AKRIKHIN began implementing an investment program for the period 2010-2016. for the modernization and development of the production complex with a total investment of more than 40 million dollars. As a result of the implementation of the investment program, the company will significantly increase the volume of output and will finally complete the transition of the entire production complex to compliance with the requirements international standards quality
Loading...
